Switzerland Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 10, 2014
106 Pages - SKU: BMI5405836
Countries covered: Switzerland

Switzerland Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The Swiss government will need to develop policies to maintain the country's long-termattractiveness as a site for clinical trials, especially as we expect cost of conducting clinical research torise. The drivers of increased attractiveness of non-traditional locations for clinical studies includeimproving healthcare infrastructure, more and better trained medical professionals, and a growingrequirement for local studies in the pharmaceutical approval process. We foresee a continuing shift inweighting towards emerging markets, especially for Phase III trials, while early-stage research is likely toremain in developed states.

Headline Expenditure Projections

Pharmaceuticals: CHF7.06bn (USD7.68bn) in 2013 to CHF7.02bn (USD7.34bn) in 2014; -0.66% inlocal currency terms and -4.4% in US dollar terms.

Healthcare: CHF68.19bn (USD74.12bn) in 2013 to CHF69.46bn (USD72.63bn) in 2014; +1.9% growthin local currency terms and -2.0% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Taiwan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Taiwan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical andhealthcare investment, ...
Sudan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sudan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The already depreciating Sudanese pound will come under further strain should oil pricescontinue their decline as oil ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly asthe government sees the ...
Myanmar Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Myanmar Pharmaceuticals and Healthcare Report Q1 2015BMI View: Non-governmental organisations will continue to expand healthcare access in Myanmar - aboon for the country's pharmaceutical market. ...
See all reports like this >>

More Switzerland Prescription Drugs reports

The Pharmaceutical Market: Switzerland by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Switzerland (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Pharmaceuticals - Switzerland by Global Research & Data Services
This market analysis gives an overview of the actual situation, trends and future outlook of the pharmaceutical market in Switzerland. The market analysis provides essential ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!